Drug intelligence / Profile preview

tryptanthrin-6-oxime

Development stage
Preclinical
Lead developer
Montana State University
Modality
Small Molecules
01

Overview

Tryptanthrin-6-oxime (TRYP-Ox) is a synthetic oxime derivative of the natural alkaloid tryptanthrin, which is found in various plants such as *Polygonum tinctorium*. It is being investigated for its anti-inflammatory and therapeutic potential in autoimmune diseases, particularly rheumatoid arthritis (RA). The compound acts as a kinase inhibitor, specifically targeting the c-Jun N-terminal kinase (JNK) signaling pathway. By inhibiting JNK, tryptanthrin-6-oxime suppresses the expression and secretion of matrix metalloproteinases (MMP-1 and MMP-3) and various proinflammatory cytokines, including IL-6, IL-17A, GM-CSF, and RANKL. In preclinical murine models of arthritis, such as collagen-induced arthritis (CIA) and collagen-antibody-induced arthritis (CAIA), tryptanthrin-6-oxime has demonstrated efficacy in reducing clinical symptoms and joint damage comparable to or exceeding that of its parent compound, while exhibiting no significant cytotoxicity in vitro.

Other names
tryptanthrin-6-oximetryptanthrin6-oximetryptanthrin 6-oxime
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)

Beyond the preview

Go deeper on tryptanthrin-6-oxime.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tryptanthrin-6-oxime.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call